BiomX (PHGE) Total Debt (2018 - 2023)
BiomX (PHGE) posted Total Debt of $11.2 million for Q4 2023, down 11.93% sequentially from $12.7 million in Q3 2023, and down 24.78% YoY from $14.9 million in Q4 2022.
BiomX (PHGE) Total Debt (2018 - 2023) Analysis & Trends
BiomX has reported Total Debt for 6 years, with the latest figure at $11.2 million in Q4 2023.
- Quarterly Total Debt fell 24.78% year-over-year to $11.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $11.2 million (down 24.78% YoY) and the FY2023 annual result came in at $11.2 million, down 24.78% from the prior year.
- Total Debt eased to $11.2 million in Q4 2023 per PHGE's latest filing, from $12.7 million in the prior quarter.
- Over five years, Total Debt peaked at $15.7 million in Q2 2022 and troughed at $500000.0 in Q1 2019.
- A 5-year average of $8.7 million and a median of $8.8 million in 2023 frame the typical range for Total Debt.
- The sharpest annual moves came in 2021 and 2023: Total Debt jumped 448.36% in 2021, then plunged 43.89% in 2023.
- Over 5 years, Total Debt stood at $1.2 million in 2019, then jumped by 378.88% to $5.9 million in 2020, then soared by 158.34% to $15.2 million in 2021, then declined by 2.34% to $14.9 million in 2022, then decreased by 24.78% to $11.2 million in 2023.
- According to Business Quant data, Total Debt over the past three periods registered $11.2 million, $12.7 million, and $8.8 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 11.19 Mn |
| Sep 30, 2023 | 12.70 Mn |
| Jun 30, 2023 | 8.81 Mn |
| Mar 31, 2023 | 15.25 Mn |
| Dec 31, 2022 | 14.87 Mn |
| Sep 30, 2022 | 15.69 Mn |
| Jun 30, 2022 | 15.71 Mn |
| Mar 31, 2022 | 14.89 Mn |
| Dec 31, 2021 | 15.23 Mn |
| Sep 30, 2021 | 15.02 Mn |
| Jun 30, 2021 | 5.67 Mn |
| Mar 31, 2021 | 5.50 Mn |
| Dec 31, 2020 | 5.90 Mn |
| Sep 30, 2020 | 4.50 Mn |
| Jun 30, 2020 | 1.03 Mn |
| Mar 31, 2020 | 1.10 Mn |
| Dec 31, 2019 | 1.23 Mn |
| Jun 30, 2019 | 500,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 550,000.00 |